Liposomes in diagnosis and treatment of cardiovascular disorders.
作者信息
Levchenko Tatyana S, Hartner William C, Torchilin Vladimir P
机构信息
Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, Massachusetts, USA.
出版信息
Methodist Debakey Cardiovasc J. 2012 Jan;8(1):36-41. doi: 10.14797/mdcj-8-1-36.
Abstract
摘要
相似文献
1
Liposomes in diagnosis and treatment of cardiovascular disorders.脂质体在心血管疾病诊断与治疗中的应用
Methodist Debakey Cardiovasc J. 2012 Jan;8(1):36-41. doi: 10.14797/mdcj-8-1-36.
2
Liposomes for cardiovascular targeting.用于心血管靶向的脂质体。
Ther Deliv. 2012 Apr;3(4):501-14. doi: 10.4155/tde.12.18.
3
Liposome technology for cardiovascular disease treatment and diagnosis.脂质体技术用于心血管疾病的治疗和诊断。
Expert Opin Drug Deliv. 2012 Feb;9(2):249-65. doi: 10.1517/17425247.2012.647908. Epub 2012 Jan 11.
4
Immunoliposomes and PEGylated immunoliposomes: possible use for targeted delivery of imaging agents.免疫脂质体和聚乙二醇化免疫脂质体：成像剂靶向递送的潜在用途。
Immunomethods. 1994 Jun;4(3):244-58. doi: 10.1006/immu.1994.1027.
5
A novel approach for establishing cardiovascular drug efficacy.一种确立心血管药物疗效的新方法。
Nat Rev Drug Discov. 2014 Dec;13(12):942. doi: 10.1038/nrd4090-c2. Epub 2014 Nov 14.
6
Pharmacogenomics in cardiology--genetics and drug response: 10 years of progress.心脏病学中的药物基因组学——遗传学与药物反应：十年进展
Future Cardiol. 2015 May;11(3):281-6. doi: 10.2217/fca.15.20.
7
The Heart's Circadian Rhythms Point to Potential Treatment Strategies.心脏的昼夜节律指向潜在的治疗策略。
Circulation. 2016 Dec 6;134(23):1907-1908. doi: 10.1161/CIRCULATIONAHA.116.026039.
8
Ultrasound techniques for drug delivery in cardiovascular medicine.心血管医学中用于药物递送的超声技术。
Curr Drug Discov Technol. 2008 Dec;5(4):328-32. doi: 10.2174/157016308786733573.
9
Future directions of liposome- and immunoliposome-based cancer therapeutics.基于脂质体和免疫脂质体的癌症治疗的未来发展方向。
Semin Oncol. 2004 Dec;31(6 Suppl 13):196-205. doi: 10.1053/j.seminoncol.2004.08.009.
10
[Value of pharmacokinetic studies in cardiology].[药代动力学研究在心脏病学中的价值]
Kardiologiia. 1989 May;29(5):5-11.
引用本文的文献
1
Organic Nanoparticles in Progressing Cardiovascular Disease Treatment and Diagnosis.有机纳米颗粒在心血管疾病治疗与诊断进展中的应用
Polymers (Basel). 2024 May 16;16(10):1421. doi: 10.3390/polym16101421.
2
Recent Advances in Anti-Atherosclerosis and Potential Therapeutic Targets for Nanomaterial-Derived Drug Formulations.纳米材料药物制剂在抗动脉粥样硬化及潜在治疗靶点方面的最新进展
Adv Sci (Weinh). 2023 Oct;10(29):e2302918. doi: 10.1002/advs.202302918. Epub 2023 Sep 12.
3
Optimization and Characterization of a Liposomal Azithromycin Formulation for Alternative Macrophage Activation.用于替代性巨噬细胞活化的脂质体阿奇霉素制剂的优化与表征
Front Drug Deliv. 2022;2. doi: 10.3389/fddev.2022.908709. Epub 2022 Jul 5.
4
Nanoparticles Targeting the Molecular Pathways of Heart Remodeling and Regeneration.靶向心脏重塑与再生分子途径的纳米颗粒
Pharmaceutics. 2022 Mar 26;14(4):711. doi: 10.3390/pharmaceutics14040711.
5
High-Molecular-Weight Fractions of Spruce and Eucalyptus Lignin as a Perspective Nanoparticle-Based Platform for a Therapy Delivery in Liver Cancer.云杉和桉树木质素的高分子量级分作为基于纳米颗粒的肝癌治疗递送的潜在平台
Front Bioeng Biotechnol. 2022 Feb 7;9:817768. doi: 10.3389/fbioe.2021.817768. eCollection 2021.
6
A Comprehensive Review on the Applications of Exosomes and Liposomes in Regenerative Medicine and Tissue Engineering.外泌体和脂质体在再生医学与组织工程中的应用综述
Polymers (Basel). 2021 Jul 30;13(15):2529. doi: 10.3390/polym13152529.
7
Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction.脂质体递送阿奇霉素增强其免疫治疗效果并降低心肌梗死的毒性。
Sci Rep. 2020 Oct 6;10(1):16596. doi: 10.1038/s41598-020-73593-0.
8
Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases.基于常规技术和纳米技术的方法来对抗慢性阻塞性肺疾病：对慢性气道疾病的影响。
Int J Nanomedicine. 2020 May 28;15:3803-3826. doi: 10.2147/IJN.S242516. eCollection 2020.
9
Evaluation of pharmacokinetic and pharmacodynamic profiles of liposomes for the cell type-specific delivery of small molecule drugs.脂质体用于小分子药物的细胞类型特异性递送的药代动力学和药效学特征评价。
Nanomedicine. 2017 Nov;13(8):2565-2574. doi: 10.1016/j.nano.2017.07.005. Epub 2017 Jul 25.
10
Tissue plasminogen activator-based clot busting: Controlled delivery approaches.基于组织型纤溶酶原激活剂的血栓溶解：控释方法。
Glob Cardiol Sci Pract. 2014 Oct 16;2014(3):336-49. doi: 10.5339/gcsp.2014.46. eCollection 2014.
本文引用的文献
1
Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques.载有脂联素的纳米颗粒增强动脉粥样硬化斑块的成像。
Int J Nanomedicine. 2011;6:1279-90. doi: 10.2147/IJN.S18739. Epub 2011 Jun 21.
2
Development and physico-chemical characterization of a liposomal formulation of istaroxime.伊曲卡肟脂质体制剂的研制及其理化特性研究。
Eur J Pharm Biopharm. 2011 Oct;79(2):285-93. doi: 10.1016/j.ejpb.2011.04.013. Epub 2011 Apr 29.
3
Theranostic nanomedicine.治疗诊断纳米医学。
Acc Chem Res. 2011 Oct 18;44(10):1029-38. doi: 10.1021/ar200019c. Epub 2011 May 5.
4
Ultrasound-enhanced thrombolytic effect of tissue plasminogen activator-loaded echogenic liposomes in an in vivo rabbit aorta thrombus model--brief report.载组织型纤溶酶原激活剂声振微泡对兔体内腹主动脉血栓溶栓作用的初步研究
Arterioscler Thromb Vasc Biol. 2011 Jun;31(6):1357-9. doi: 10.1161/ATVBAHA.111.225938. Epub 2011 Mar 24.
5
Transmembrane pH-gradient liposomes to treat cardiovascular drug intoxication.跨膜 pH 梯度脂质体治疗心血管药物中毒。
ACS Nano. 2010 Dec 28;4(12):7552-8. doi: 10.1021/nn101924a. Epub 2010 Nov 10.
6
Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis.多模态临床影像学纵向评估纳米医学抗炎治疗实验性动脉粥样硬化。
Mol Pharm. 2010 Dec 6;7(6):2020-9. doi: 10.1021/mp100309y. Epub 2010 Nov 8.
7
Development and characterization of site specific target sensitive liposomes for the delivery of thrombolytic agents.用于溶栓药物传递的靶向敏感脂质体的制备及特性研究。
Int J Pharm. 2011 Jan 17;403(1-2):254-61. doi: 10.1016/j.ijpharm.2010.10.028. Epub 2010 Oct 31.
8
An ultrasound-responsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy.一种组织型纤溶酶原激活物的超声响应型纳米递药系统用于溶栓治疗。
J Control Release. 2010 Oct 15;147(2):269-77. doi: 10.1016/j.jconrel.2010.07.127. Epub 2010 Aug 6.
9
Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel ex vivo mouse aorta model.超声增强靶向声敏脂质体在新型离体小鼠主动脉模型中的传递。
J Control Release. 2010 Jun 15;144(3):288-95. doi: 10.1016/j.jconrel.2010.02.030. Epub 2010 Mar 2.
10
Construction of thrombus-targeted microbubbles carrying tissue plasminogen activator and their in vitro thrombolysis efficacy: a primary research.构建携带组织型纤溶酶原激活剂的靶向血栓微泡及其体外溶栓效果的初步研究。
J Thromb Thrombolysis. 2010 Jul;30(1):29-35. doi: 10.1007/s11239-010-0450-z.
Zotero 插件